← The library
Cardiogen
AEDR tetrapeptide bioregulatorCardio/VascularEvidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
PurposeCardiac bioregulator
MechanismAla-Glu-Asp-Arg tetrapeptide from the Khavinson family, studied for cardiac-tissue signalling.
EffectsStudied for heart tissue and cardiovascular ageing.
DosingNo human dose established.
Bottom lineNamed for the heart, but with no controlled cardiovascular trial behind it.
Batches on filenone
No tested batches on file.
Read with
The library records no pairings for this entry.
Cautions & interactions
No validated clinical use. Evidence base is one group’s preclinical work plus Russian observational reports.
No interaction data published.
CV 1 of 5 — Cardiac tissue is the stated target. No controlled trial has measured a cardiovascular endpoint.